ConductScience.org, home

Paper39769262

Galectin Plasmatic Levels Reveal a Cluster Associated with Disease Aggressiveness and Kidney Damage in Multiple Myeloma Patients.

Carvalho LVDN and 6 others. Int J Mol Sci, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Galectin Plasmatic Levels Reveal a Cluster Associated with Disease Aggressiveness and Kidney Damage in Multiple Myeloma Patients. Papers, record 39769262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39769262

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Galectin Plasmatic Levels Reveal a Cluster Associated with Disease Aggressiveness and Kidney Damage in Multiple Myeloma Patients.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.92, provisional
iCite
Revised in PubMed
2025-01-08
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carvalho LVDNLidiane Vasconcelos do Nascimento
2Assis RAReijane Alves
3Montenegro CClaudio
4da Rosa MMMichelle Melgarejohttps://orcid.org/0000-0002-0163-3833
5Pereira MCMichelly Cristinyhttps://orcid.org/0000-0002-1672-8202
6Pitta MGDRMaira Galdino da Rocha
7de Melo Rêgo MJBMoacyr Jesus Barretohttps://orcid.org/0000-0002-1883-6012

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Multiple MyelomaMajor topic
GalectinsMajor topic
Humans
Female
Male
Middle Aged
Aged
Prognosis
Kidney
Aged, 80 and over
Adult
Biomarkers, Tumor

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
n/aCoordenação de Aperfeiçoamento de Pessoal de Nível SuperiorPubMed
n/aConselho Nacional de Desenvolvimento Científico e TecnológicoPubMed

Source PubMed

Download CSV of grants

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137569679Galectin-4 Is Involved in the Structural Changes of Glycosphingolipid Glycans in Poorly Differentiated Gastric Cancer Cells with High Metastatic Potential.Int J Mol Sci2023https://conductscience.org/library/papers/37569679PubMed
220200560Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.Leukemia2010https://conductscience.org/library/papers/20200560PubMed
334290359Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma.Leukemia2022https://conductscience.org/library/papers/34290359PubMed
422026577The fibrosis marker galectin-3 and outcome in the general population.J Intern Med2012https://conductscience.org/library/papers/22026577PubMed
524477688Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice.Am J Physiol Renal Physiol2014https://conductscience.org/library/papers/24477688PubMed
632138174Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases.Biomolecules2020https://conductscience.org/library/papers/32138174PubMed
738868715Complex heatmap visualization.Imeta2022https://conductscience.org/library/papers/38868715PubMed
821912250Galectins and microenvironmental niches during hematopoiesis.Curr Opin Hematol2011https://conductscience.org/library/papers/21912250PubMed
934195077Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma.Front Oncol2021https://conductscience.org/library/papers/34195077PubMed
1039539619The regulating role of galectin-9 in immune cell populations.Front Pharmacol2024https://conductscience.org/library/papers/39539619PubMed
1130813402Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts.Cancers (Basel)2019https://conductscience.org/library/papers/30813402PubMed
1229975570Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes.FASEB J2019https://conductscience.org/library/papers/29975570PubMed
1328435287Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation.Onco Targets Ther2017https://conductscience.org/library/papers/28435287PubMed
1433771821Myeloma-Secreted Galectin-1 Potently Interacts with CD304 on Monocytic Myeloid-Derived Suppressor Cells.Cancer Immunol Res2021https://conductscience.org/library/papers/33771821PubMed
1535687787Plasma Galectin-9 Is a Useful Biomarker for Predicting Renal Function in Patients Undergoing Native Kidney Biopsy.Arch Pathol Lab Med2023https://conductscience.org/library/papers/35687787PubMed
1617325894Renal failure in multiple myeloma: incidence, correlations, and prognostic significance.Leuk Lymphoma2007https://conductscience.org/library/papers/17325894PubMed
1728801238A Co-Inhibitory Alliance in Myeloid Leukemia: TIM-3/Galectin-9 Complex as a New Target for Checkpoint Blockade Therapy.EBioMedicine2017https://conductscience.org/library/papers/28801238PubMed
1829258207Role of Galectins in Multiple Myeloma.Int J Mol Sci2017https://conductscience.org/library/papers/29258207PubMed
1928858976Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats.J Hypertens2018https://conductscience.org/library/papers/28858976PubMed
2037898403The universe of galectin-binding partners and their functions in health and disease.J Biol Chem2023https://conductscience.org/library/papers/37898403PubMed

See all 47 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42197247Galectin-3-A Multifunctional Molecule and a Key Player in Health and Disease.Molecules2026https://conductscience.org/library/papers/42197247PubMed
42054245Selective Nanobody-Derived Minibodies Targeting Galectin-1 and -7 Reveal Non-Redundant Glyco-Immune Functions and Therapeutic Potential in Triple-Negative Breast Cancer.J Med Chem2026https://conductscience.org/library/papers/42054245PubMed
41590658Plasma Galectin-7 (Gal-7) and Galectin-8 (Gal-8) as Emerging Biomarkers in Psoriasis: Associations with Disease Activity and Metabolic Status.Metabolites2026https://conductscience.org/library/papers/41590658PubMed
40572708Galectin-1 in Cardiovascular Pathogenesis: Unraveling Dual Roles and Mechanistic Insights in Emerging Research.Medicina (Kaunas)2025https://conductscience.org/library/papers/40572708PubMed
40362377Acridine-Based Chalcone 1C and ABC Transporters.Int J Mol Sci2025https://conductscience.org/library/papers/40362377PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HLA-G3135PubTator's text mininghttps://conductscience.org/library/genes/3135NCBI Gene
LGALS93965PubTator's text mininghttps://conductscience.org/library/genes/3965NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39769262

GET https://conductscience.org/api/papers/v1/39769262/references?page=2